Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -114.09%-2.93M | -324.26%-2.78M | -41.91%-2.5M | -54.86%-5.45M | -100.71%-1.66M | -316.11%-1.37M | 59.62%-654.72K | -138.58%-1.76M | 55.36%-3.52M | 24.73%-829.29K |
| Net income from continuing operations | 40.67%-1.96M | -0.52%-1.95M | -104.57%-2.5M | -17.72%-10.16M | -11.08%-3.7M | -100.99%-3.3M | 11.93%-1.94M | 16.28%-1.22M | 21.24%-8.63M | -7.17%-3.33M |
| Operating gains losses | ---- | ---- | 3,314.09%279.48K | -95.10%8.19K | --0 | --0 | --0 | --8.19K | --167.16K | ---- |
| Depreciation and amortization | -8.45%194.86K | -8.43%194.82K | -8.45%194.71K | -8.58%851.93K | -9.06%213.66K | -7.03%212.84K | -9.13%212.74K | -9.07%212.68K | -9.65%931.89K | -10.98%234.94K |
| Asset impairment expenditure | 118.14%10.25K | 16.42%-2.2K | 98.93%-319 | -81.49%281.5K | -75.68%370.33K | -108.09%-56.52K | -94.61%-2.64K | -211.65%-29.68K | 22.49%1.52M | 130.25%1.52M |
| Remuneration paid in stock | -71.09%26.8K | -55.58%18.97K | 10,357.82%22.07K | 460.14%1.11M | 4,948.63%978.12K | -10.45%92.71K | -37.02%42.71K | -97.40%211 | -69.04%198.84K | -96.92%19.37K |
| Remuneration paid in stock | --0 | --0 | --65.62K | --1.75M | --293.43K | --1.45M | --0 | --0 | --0 | --0 |
| Other non cashItems | -496.04%-84.38K | 1,000.57%361.61K | 85.59%122.34K | -62.38%312.02K | -21.89%191.94K | -92.19%21.31K | -87.09%32.86K | 17.18%65.92K | 288.38%829.38K | 997.31%245.73K |
| Change In working capital | -628.23%-1.11M | -213.22%-1.13M | 14.01%-685.48K | -72.86%397.45K | -103.56%-11.13K | -71.36%210.97K | 4,654.34%994.75K | -301.93%-797.14K | 223.19%1.46M | 1.00%312.15K |
| -Change in receivables | -252.90%-89.38K | 89.31%-64.28K | -187.39%-193.93K | -149.22%-463.52K | -6.71%-142.35K | 228.74%58.46K | -780.32%-601.52K | 262.87%221.9K | -237.91%-185.99K | -228.45%-133.4K |
| -Change in inventory | -138.60%-215.74K | -249.14%-902.19K | 151.01%162.67K | 196.07%814.47K | 95.31%-30.54K | 1,337.60%558.92K | 1,001.55%604.95K | -89.12%-318.87K | 19.39%-847.8K | -93,430.32%-650.97K |
| -Change in prepaid assets | -85.74%10.93K | 72.88%163.39K | -6.11%-168.81K | -118.05%-31.37K | -556.37%-43.42K | 393.69%76.65K | 261.81%94.51K | -229.76%-159.1K | -12.52%173.77K | 115.73%9.51K |
| -Change in payables and accrued expense | -60.93%-810.98K | -132.77%-304.18K | 11.05%-478.51K | -97.76%45.3K | -85.02%159.02K | -168.34%-503.93K | 743.76%928.18K | -245.63%-537.97K | 2,172.97%2.02M | 113.32%1.06M |
| -Change in other working capital | -144.28%-9.25K | 39.51%-18.97K | -121.30%-6.89K | -89.15%32.57K | 82.17%46.16K | 315.09%20.88K | -111.43%-31.36K | -130.53%-3.11K | 263.97%300.25K | 110.95%25.34K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -114.09%-2.93M | -324.26%-2.78M | -41.91%-2.5M | -54.86%-5.45M | -100.71%-1.66M | -316.11%-1.37M | 59.62%-654.72K | -138.58%-1.76M | 55.36%-3.52M | 24.73%-829.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -63.42%-6.92K | 77.51%-2.36K | 20.07%-44.49K | 11.21%-7.06K | -73.07%-22.69K | 75.77%-4.23K | 38.65%-10.51K | 42.46%-55.66K | 44.32%-7.95K |
| Net PPE purchase and sale | --0 | --0 | --0 | ---10.85K | ---7.06K | --0 | --0 | ---3.8K | --0 | --0 |
| Net intangibles purchas and sale | --0 | -63.42%-6.92K | 64.78%-2.36K | 75.51%-13.63K | --0 | 79.50%-2.69K | 75.77%-4.23K | 60.83%-6.71K | 42.46%-55.66K | 44.32%-7.95K |
| Net business purchase and sale | ---- | ---- | ---- | ---20K | --0 | ---- | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -63.42%-6.92K | 77.51%-2.36K | 20.07%-44.49K | 11.21%-7.06K | -73.07%-22.69K | 75.77%-4.23K | 38.65%-10.51K | 42.46%-55.66K | 44.32%-7.95K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 593.73%4.27M | -74.59%330.89K | 239.36%5.62M | 45.49%5.33M | 70.06%1.75M | 88.25%614.97K | -22.94%1.3M | 169.56%1.66M | 1,872.43%3.66M | 890.80%1.03M |
| Net issuance payments of debt | 52.02%-225.48K | 0.09%-125.45K | 597.54%624.58K | -136.25%-971.1K | -112.21%-250.06K | -243.85%-469.93K | 59.55%-125.57K | -120.42%-125.53K | 973.45%2.68M | 1,669.05%2.05M |
| Net common stock issuance | 314.02%4.49M | -69.19%439.84K | 180.44%5M | 336.33%4.3M | --0 | --1.08M | -28.62%1.43M | --1.78M | --984.45K | ---1.02M |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --2M | --2M | --0 | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 593.73%4.27M | -74.59%330.89K | 239.36%5.62M | 45.49%5.33M | 70.06%1.75M | 88.25%614.97K | -22.94%1.3M | 169.56%1.66M | 1,872.43%3.66M | 890.80%1.03M |
| Net cash flow | ||||||||||
| Beginning cash position | -2.56%757.6K | 2,289.13%3.21M | -65.10%86.3K | 58.00%247.27K | -94.47%2.91K | 1,052.22%777.5K | 708.35%134.41K | 58.00%247.27K | -98.12%156.5K | -96.25%52.57K |
| Current changes in cash | 272.97%1.34M | -481.55%-2.45M | 2,869.05%3.13M | -277.34%-160.97K | -57.17%83.39K | -5,095.09%-774.59K | 1,164.66%643.08K | 19.31%-112.86K | 101.11%90.77K | 115.62%194.7K |
| End cash Position | 72,051.32%2.1M | -2.56%757.6K | 2,289.13%3.21M | -65.10%86.3K | -65.10%86.3K | -94.47%2.91K | 1,052.22%777.5K | 708.35%134.41K | 58.00%247.27K | 58.00%247.27K |
| Free cash from | -113.67%-2.93M | -322.58%-2.78M | -41.20%-2.5M | -53.13%-5.47M | -99.65%-1.67M | -300.93%-1.37M | 59.79%-658.95K | -134.56%-1.77M | 55.20%-3.57M | 24.98%-837.24K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unaudited | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.